Page last updated: 2024-08-24

triptonide and Carcinogenesis

triptonide has been researched along with Carcinogenesis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Cao, Z; Meng, M; Xiang, S; Zhang, B; Zhang, T; Zhao, Z; Zhou, Q1
Cao, Z; Dong, L; Huo, Z; Lv, C; Meng, M; Shi, S; Xiang, S; Xu, X; Yang, B; Yang, L; Zhang, B; Zhang, G; Zhang, P; Zhao, Z; Zhou, Q1
Chen, Y; Gao, Y; Jia, Y; Liu, X; Ma, D; Wang, C; Wang, Z; Yang, Y; Yuan, J; Zeng, F; Zhu, Z1
Cao, Z; Chen, B; Li, Y; Meng, M; Xiang, S; Xu, X; Yang, P; Zhang, B; Zhang, T; Zhao, Z; Zhou, Q1
Cao, Z; Meng, M; Pan, Y; Xi, X; Yang, P; Zheng, N; Zhou, Q1

Other Studies

5 other study(ies) available for triptonide and Carcinogenesis

ArticleYear
Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-κB signaling pathways.
    Toxicology and applied pharmacology, 2020, 02-01, Volume: 388

    Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Phosphorylation; Proteasome Endopeptidase Complex; Proteolysis; Receptor, Notch1; Signal Transduction; Stomach Neoplasms; Triterpenes; Xenograft Model Antitumor Assays

2020
The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapy.
    Cell death and differentiation, 2020, Volume: 27, Issue:8

    Topics: Animals; Apoptosis; Carcinogenesis; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Repair; DNA Repair Enzymes; Female; Gene Expression Regulation, Neoplastic; Humans; Lipogenesis; Liver X Receptors; Mice, Nude; Mitosis; Models, Biological; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); RNA, Messenger; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Transcription, Genetic; Triterpenes; Tumor Suppressor Protein p53

2020
Triptonide inhibits the pathological functions of gastric cancer-associated fibroblasts.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 96

    Topics: Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Epithelial-Mesenchymal Transition; Fibroblasts; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; MicroRNAs; Neoplasm Invasiveness; Oncogenes; Stomach; Stomach Neoplasms; Triterpenes; Up-Regulation

2017
Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth.
    Biochemical pharmacology, 2019, Volume: 166

    Topics: Animals; Carcinogenesis; Enzyme Activation; Female; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred NZB; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Pancreatic Neoplasms; Random Allocation; Treatment Outcome; Triterpenes; Tumor Burden; Xenograft Model Antitumor Assays

2019
Targeting of multiple senescence-promoting genes and signaling pathways by triptonide induces complete senescence of acute myeloid leukemia cells.
    Biochemical pharmacology, 2017, Feb-15, Volume: 126

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinogenesis; Cell Proliferation; Cellular Senescence; Drug Screening Assays, Antitumor; Female; HL-60 Cells; Humans; Leukemia, Experimental; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Signal Transduction; Tripterygium; Triterpenes; U937 Cells

2017